Follow the podcast on Spotify, Apple Podcasts, and YouTube
Observed reductions in BP after 68 weeks of CagriSema treatment versus placebo were greater than those previously observed over the same time frame for semaglutide 2.4 mg in participants with overweight or obesity in the Semaglutide Treatment Effect in People with Obesity (STEP) 1, STEP 3, and STEP 4 trials, with an overall reduction in SBP versus placebo across the 3 trials of 5.0 (95% CI, 5.9 to 4.1) mm Hg
Ferrostatin-1 Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting Ferroptosis
Shortening Recovery Post-workout recovery accelerates with adequate B12 due to its involvement in protein synthesis and tissue repair
Preclinical study has suggested that vitamin B12 has potential cardiovascular metabolic benefits, including reducing oxidative stress and improving insulin resistance [26]
Across the six published trials, the most common adverse events were headache, mild gastrointestinal effects (diarrhea, flatulence, nausea), nasopharyngitis, fatigue, dizziness, and mild injection-site reactions
